21 avril 2022 – Due to various legal amendments in recent years on the Federal Health Insurance Act (KVG), Federal Therapeutic Products Act (TPA) and the Federal Ordinance on Integrity and Transparency in relation to Therapeutic Products (TPITO), the Association of Medical Laboratories in Switzerland (FAMH) and several leading players in laboratory medicine have developed a Laboratory Code of Conduct, which entered into force on 1 April 2022. The FAMH Laboratory Code of Conduct is intended to make it easier for laboratory medicine and other health actors to orient themselves in a complex regulatory environment. It will thus provide the basis for fair and equitable competition among the health actors involved and promote the confidence of patients, customers, politicians and financiers. The FAMH Laboratory Code of Conduct enables all signatories to formally commit to business practices that meet the highest ethical and commercial requirements.

The FAMH Laboratory Code of Conduct (in German) is available here.

For more information, see here.